Adaptive Pulse Wave Analysis for Blood Pressure Monitoring

The USPTO issued Patent US12605080B2 to Senbiosys for an adaptive pulse wave analysis technique used in blood pressure monitoring. The invention transforms pulsatility signals to better define fiducial points required for pulse wave analysis, resulting in improved blood pressure estimation accuracy. The patent covers CPC classifications related to cardiovascular measurement devices.

Entities developing photoplethysmography-based blood pressure monitoring products should review this patent when designing adaptive signal processing features. The patent's 15 claims define specific transformations of pulsatility signals for fiducial point identification, which could be relevant to companies engineering similar physiological monitoring capabilities.